An engine for new medicines: A century of science changing life
Calibr, a nonprofit research institute founded by Scripps Research President and CEO Pete Schultz, joined Scripps Research in 2018 as its drug discovery division. As a world-class nonprofit “bench to bedside” drug discovery engine, Calibr delivers groundbreaking solutions to unmet medical needs by uniting the creativity of fundamental discovery with highly focused R&D capabilities and expertise.
Centennial
Calibr-Skaggs
Drug Discovery
Aging & Healthspan
Cancer
Centennial
Drug Discovery
Infectious Diseases
multiple sclerosis
Neurological Disorders